A Call for Collective Responsibility in Rare Disease Communities
The IRA & Uncertain Times for US Pharma
COP28 & Pharma’s Green Horizon
Regulatory Focus: Brazil’s ANVISA
Faced with IRA Challenges, BIO Names New CEO: Washington Fixture John Crowley
The Evolution of US FDA Diversity Requirements in Clinical Research
3 Essential Characteristics for AI Impact in Clinical Research
Eli Lilly: The World’s First Trillion-Dollar Pharma Company?
Brazil Pharma News: Biophytis/Innovation Solutions Partnership; Eurofarma’s Major Biotech Investment
All Change at the Top: 13 New Pharma CEOs in 2023
New NIH Director Bertagnolli to Focus on Access
New FDA Guidance Addresses Challenges with Cell and Gene Manufacturing Comparability and Complexity
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here